scispace - formally typeset
F

Fernando Dangond

Researcher at Merck Serono

Publications -  106
Citations -  4371

Fernando Dangond is an academic researcher from Merck Serono. The author has contributed to research in topics: Cladribine & Interferon beta-1a. The author has an hindex of 29, co-authored 101 publications receiving 3788 citations. Previous affiliations of Fernando Dangond include Merck KGaA & Bayer.

Papers
More filters
Journal ArticleDOI

Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions.

TL;DR: Findings indicate that an early event in the initiation of MS involves upregulation of B7-1 and IL-12, resulting in conditions that maximally stimulate T cell activation and induction of T helper 1-type immune responses.
Journal ArticleDOI

Sodium phenylbutyrate prolongs survival and regulates expression of anti‐apoptotic genes in transgenic amyotrophic lateral sclerosis mice

TL;DR: Evidence is provided that the pharmacological induction of NF‐κB‐dependent transcription and bcl‐2 gene expression is neuroprotective in ALS mice by inhibiting programmed cell death and Phenylbutyrate may provide a novel therapeutic approach for the treatment of patients with ALS.